Boothbay Fund Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-14,000
Closed -$126K – 1582
2023
Q4
$126K Sell
14,000
-163
-1% -$1.34K ﹤0.01% 1404
2023
Q3
$110K Buy
+14,163
New +$139K ﹤0.01% 1550
2020
Q3
– Sell
-35,638
Closed -$579K – 1041
2020
Q2
$579K Buy
35,638
+138
+0.4% +$2.21K 0.04% 508
2020
Q1
$515K Sell
35,500
-50,428
-59% -$889K 0.04% 462
2019
Q4
$1.74M Buy
+85,928
New +$792K 0.15% 187
2019
Q2
– Sell
-80,000
Closed -$510K – 733
2019
Q1
$520K Buy
+80,000
New +$531K 0.05% 371
2018
Q4
– Sell
-77,913
Closed -$517K – 663
2018
Q3
$517K Buy
77,913
+41,913
+116% +$235K 0.05% 354
2018
Q2
$203K Buy
+36,000
New +$201K 0.02% 627
2017
Q4
– Sell
-12,726
Closed -$80K – 716
2017
Q3
$80K Buy
+12,726
New +$80.2K 0.01% 559
2017
Q2
– Sell
-17,614
Closed -$129K – 667
2017
Q1
$129K Buy
+17,614
New +$81.4K 0.02% 656
2016
Q4
– Sell
-16,345
Closed -$49K – 753
2016
Q3
$49K Buy
+16,345
New +$44.1K 0.01% 684

Other funds holding AUPH

Boothbay Fund Management's AUPH Position: Q1 2024 in Review

Boothbay Fund Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 14,000 shares — an estimated $126K sold.

Boothbay Fund Management first reported a position in AUPH in Q3 2016 and held it in 11 quarters. The position peaked at $1.74M in Q4 2019. 177 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Boothbay Fund Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 14,000 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $126K.
  • Boothbay Fund Management first reported a position in Aurinia Pharmaceuticals in Q3 2016 and held it in 11 quarters.
  • Boothbay Fund Management's Aurinia Pharmaceuticals position peaked at $1.74M in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.